| 000 | 02580nam a2200349 a 4500 | ||
|---|---|---|---|
| 005 | 20250918153030.0 | ||
| 008 | 120402s2012 nyua b 001 0 eng | ||
| 020 |
_a9781461406129 _cRM566.35 |
||
| 020 | _a1461406129 | ||
| 039 | 9 |
_a201206211052 _bruzini _c201205031210 _dyusri _c201204050922 _dyusri _y04-02-2012 _zrazalis |
|
| 040 | _aUKM | ||
| 090 | _aQW568.N285 2012 9 | ||
| 090 |
_aQW568 _b.N285 2012 9 |
||
| 245 | 0 | 0 |
_aNatural killer T cells : _bbalancing the regulation of tumor immunity / _cMasaki Terabe, Jay A. Berzofsky, editors. |
| 260 |
_aNew York : _bSpringer, _cc2012. |
||
| 300 |
_axi, 205 p. : _bill. (some col.) ; _c24 cm. |
||
| 490 | 1 | _aCancer drug discovery and development | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aIntroduction : mechanisms of NKT-cell-mediated adjuvant activity and function of iPS-derived NKT cells / Masaru Taniguchi ... [et al.] -- Structure and recognition of antigens for invariant NKT cells / Bo Pei and Mitchell Kronenberg -- Invariant NKT cell-based vaccine strategies / John-Paul Jukes ... [et al.] -- Immune regulation of tumor immunity by NKT cells / Jessica J. O'Konek, Jay A. Berzofsky, and Masaki Terabe -- The regulation of CD1d+ and CD1d- tumors by NKT cells : the roles of NKT cells in regulating CD1d+ and CD1d- tumor immunity / Jianyun Liu, Gourapura J. Renukaradhya, and Randy R. Brutkiewicz -- DC-based immunotherapy targeting NKT cells / Shin-ichiro Fujii and Kanako Shimizu -- Therapeutic approaches utilising NKT cells / Stephen R. Mattarollo and Mark J. Smyth -- NKT cells or cancer patients and how models can inform therapeutic plans / Mark A. Exley, Lydia Lynch, and Michael Nowak -- Understanding the role of natural killer T cells in hematologic malignancies : progress and challenges / Natalia Neparidze and Madhav V. Dhodapkar -- Clinical trials with alpha-galactosylceramide (KRN7000) in advanced cancer / Famke L. Schneiders ... [et al.] -- Clinical trials of invariant natural killer T cell-based immunotherapy for cancer / Shinichiro Motohashi, Yoshitaka Okamoto, and Toshinori Nakayama. | |
| 650 | 2 |
_aNatural Killer T-Cells _ximmunology. |
|
| 650 | 2 | _aCytotoxicity, Immunologic. | |
| 650 | 2 | _aImmune Tolerance. | |
| 700 | 1 | _aTerabe, Masaki. | |
| 700 | 1 | _aBerzofsky, Jay A. | |
| 830 | 0 | _aCancer drug discovery and development. | |
| 907 |
_a.b1531117x _b2021-05-28 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQW568.N285 2012 9 |
||
| 914 | _avtls003495035 | ||
| 991 | _aFakulti Farmasi KKL | ||
| 998 |
_ad _b2012-02-04 _cm _da _feng _gnyu _y0 _z.b1531117x |
||
| 999 |
_c514972 _d514972 |
||